Abstract
The fragment-based drug design approach consists of screening libraries of fragment-like ligands, to identify hits that typically bind the protein target with weak affinity (\(100\,\upmu \hbox {M}\)–5 mM). The determination of the protein–fragment complex 3D structure constitutes a crucial step for uncovering the key interactions responsible for the protein–ligand recognition, and for growing the initial fragment into potent active compounds. The vast majority of fragments are aromatic compounds that induce chemical shift perturbations (CSP) on protein NMR spectra. These experimental CSPs can be quantitatively used to guide the ligand docking, through the comparison between experimental CSPs and CSP back-calculation based on the ring current effect. Here we implemented the CSP back-calculation into the scoring function of the program PLANTS. We compare the results obtained with CSPs measured either on amide or aliphatic protons of the human peroxiredoxin 5. We show that the different kinds of protons lead to different results for resolving the 3D structures of protein–fragment complexes, with the best results obtained with the \(\hbox {H}_{\alpha }\) protons.
Similar content being viewed by others
References
Aguirre C, ten Brink T, Walker O, Guillière F, Davesne D, Krimm I (2013) BcL-xL conformational changes upon fragment binding revealed by NMR. PLoS One 8(5):e64,400
Aguirre C, ten Brink T, Guichou JF, Cala O, Krimm I (2014) Comparing binding modes of analogous fragments using NMR in fragment-based drug design: application to PRDX5. PLoS One 9(7):e102,300
Barelier S, Linard D, Pons J, Clippe A, Knoops B, Lancelin JM, Krimm I (2010) Discovery of fragment molecules that bind the human peroxiredoxin 5 active site. PLoS One 5(3):e9744
Bissantz C, Kuhn B, Stahl M (2010) A medicinal chemists guide to molecular interactions. J Med Chem 53(14):5061–5084
Caliandro R, Belviso DB, Aresta BM, de Candia M, Altomare CD (2013) Protein crystallography and fragment-based drug design. Future Med Chem 5(10):1121–1140
Cioffi M, Hunter CA, Packer MJ, Spitaleri A (2008) Determination of protein–ligand binding modes using complexation-induced changes in (1)H NMR chemical shift. J Med Chem 51(8):2512–2517
Cioffi M, Hunter CA, Packer MJ, Pandya MJ, Williamson MP (2009) Use of quantitative (1)H NMR chemical shift changes for ligand docking into barnase. J Biomol NMR 43(1):11–19
Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6(3):277–293
Dominguez C, Boelens R, Bonvin AMJJ (2003) HADDOCK: a protein–protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125(7):1731–1737
Gans P, Hamelin O, Sounier R, Ayala I, Durá MA, Amero CD, Noirclerc-Savoye M, Franzetti B, Plevin MJ, Boisbouvier J (2010) Stereospecific isotopic labeling of methyl groups for NMR spectroscopic studies of high-molecular-weight proteins. Angew Chem Int Ed Engl 49(11):1958–1962
Goddard TD, Kneller DG (2004) Sparky 3. University of California, San Fransisco, CA
González-Ruiz D, Gohlke H (2009) Steering protein–ligand docking with quantitative NMR chemical shift perturbations. J Chem Inf Model 49(10):2260–2271
Gorczynski MJ, Grembecka J, Zhou Y, Kong Y, Roudaia L, Douvas MG, Newman M, Bielnicka I, Baber G, Corpora T, Shi J, Sridharan M, Lilien R, Donald BR, Speck NA, Brown ML, Bushweller JH (2007) Allosteric inhibition of the protein–protein interaction between the leukemia-associated proteins Runx1 and CBF\(\beta \). Chem Biol 14(10):1186–1197
Harner MJ, Frank AO, Fesik SW (2013) Fragment-based drug discovery using NMR spectroscopy. J Biomol NMR 56(2):65–75
Hunter CA, Packer MJ (1999) Complexation-induced changes in \(^1\)H NMR chemical shift for supramolecular structure determination. Chem Eur J 5(6):1891–1897
Johnson BA, Blevins RA (1994) NMR view: a computer program for the visualization and analysis of NMR data. J Biomol NMR 4(5):603–614
Korb O, Stützle T, Exner TE (2007) An ant colony optimization approach to flexible protein–ligand docking. Swarm Intell 2(1):115–134
Korb O, Stützle T, Exner TE (2009) Empirical scoring functions for advanced protein–ligand docking with PLANTS. J Chem Inf Model 49(1):84–96
Korb O, Möller HM, Exner TE (2010) NMR-guided molecular docking of a protein–peptide complex based on ant colony optimization. ChemMedChem 5(7):1001–1006
Kuo LC (2011) Fragment-based drug design: tools, practical approaches, and exemples. Academic Press, San Diego 591 p
Laskowski RA, Swindells MB (2011) Ligplot+: multiple ligand–protein interaction diagrams for drug discovery. J Chem Inf Model 51(10):2778–2786
McCoy MA, Wyss DF (2000) Alignment of weakly interacting molecules to protein surfaces using simulations of chemical shift perturbations. J Biomol NMR 18(3):189–198
Medek A, Hajduk PJ, Mack J, Fesik SW (2000) The use of differential chemical shifts for determining the binding site location and orientation of protein-bound ligands. J Am Chem Soc 122(6):1241–1242
Moon S, Case DA (2007) A new model for chemical shifts of amide hydrogens in proteins. J Biomol NMR 38(2):139–150
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785–2791
Neal S, Nip AM, Zhang H, Wishart DS (2003) Rapid and accurate calculation of protein \(^1\)H, \(^{13}\)C and \(^{15}\)N chemical shifts. J Biomol NMR 26(3):215–240
Neri D, Szyperski T, Otting G, Senn H, Wüthrich K (1989) Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling. Biochemistry 28(19):7510–7516
Nielsen JT, Eghbalnia HR, Nielsen NC (2012) Chemical shift prediction for protein structure calculation and quality assessment using an optimally parameterized force field. Prog Nucl Magn Reson Spectrosc 60:1–28
Ösapay K, Case DA (1991) A new analysis of proton chemical shifts in proteins. J Am Chem Soc 113(25):9436–9444
Parker LL, Houk AR, Jensen JH (2006) Cooperative hydrogen bonding effects are key determinants of backbone amide proton chemical shifts in proteins. J Am Chem Soc 128(30):9863–9872
Permi P, Tossavainen H, Hellman M (2004) Efficient assignment of methyl resonances: enhanced sensitivity by gradient selection in a DE-MQ-(H)CC(m)H(m)-TOCSY experiment. J Biomol NMR 30(3):275–282
Plevin MJ, Hamelin O, Boisbouvier J, Gans P (2011) A simple biosynthetic method for stereospecific resonance assignment of prochiral methyl groups in proteins. J Biomol NMR 49(2):61–67
Pople J (1958) Molecular orbital theory of aromatic ring currents. Mol Phys 1(2):175–180
Pople JA (1956) Proton magnetic resonance of hydrocarbons. J Chem Phys 24(5):1111–1111
Riedinger C, Endicott JA, Kemp SJ, Smyth LA, Watson A, Valeur E, Golding BT, Griffin RJ, Hardcastle IR, Noble ME, McDonnell JM (2008) Analysis of chemical shift changes reveals the binding modes of isoindolinone inhibitors of the MDM2-p53 interaction. J Am Chem Soc 130(47):16,038–16,044
Schieborr U, Vogtherr M, Elshorst B, Betz M, Grimme S, Pescatore B, Langer T, Saxena K, Schwalbe H (2005) How much NMR data is required to determine a protein–ligand complex structure? ChemBioChem 6(10):1891–1898
Shah DM, AB E, Diercks T, Hass MAS, van Nuland NAJ, Siegal G (2012) Rapid protein–ligand costructures from sparse NOE data. J Med Chem 55(23):10,786–10,790
Shen Y, Bax A (2007) Protein backbone chemical shifts predicted from searching a database for torsion angle and sequence homology. J Biomol NMR 38(4):289–302
Shuker SB, Hajduk PJ, Meadows RP, Fesik SW (1996) Discovering high-affinity ligands for proteins: SAR by NMR. Science 274(5292):1531–1534
Stark J, Powers R (2008) Rapid protein–ligand costructures using chemical shift perturbations. J Am Chem Soc 130(2):535–545
Williamson MP (2013) Using chemical shift perturbation to characterise ligand binding. Prog Nucl Magn Reson Spectrosc 73:1–16
Wishart DS (2011) Interpreting protein chemical shift data. Prog Nucl Magn Reson Spectrosc 58:62–87
Wishart DS, Case DA (2001) Use of chemical shifts in macromolecular structure determination. Methods Enzymol 338:3–34
Würtz P, Hellman M, Tossavainen H, Permi P (2006) Towards unambiguous assignment of methyl-containing residues by double and triple sensitivity-enhanced HCCmHm-TOCSY experiments. J Biomol NMR 36(1):13–26
Wyss DF, Arasappan A, Senior MM, Wang YS, Beyer BM, Njoroge FG, McCoy MA (2004) Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening. J Med Chem 47(10):2486–2498
Yang D, Zheng Y, Liu D, Wyss DF (2004) Sequence-specific assignments of methyl groups in high-molecular weight proteins. J Am Chem Soc 126(12):3710–3711
Acknowledgments
Financial support from the TGIR-RMN-THC Fr3050 CNRS for conducting the research is gratefully acknowledged. The authors want to thank the ANR (Agence Nationale de la Recherche), ANR-11-JS07-0008, for financial support.
Author information
Authors and Affiliations
Corresponding author
Additional information
Clémentine Aguirre and Tim ten Brink contributed equally to this work.
Rights and permissions
About this article
Cite this article
Aguirre, C., ten Brink, T., Cala, O. et al. Protein–ligand structure guided by backbone and side-chain proton chemical shift perturbations. J Biomol NMR 60, 147–156 (2014). https://doi.org/10.1007/s10858-014-9864-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10858-014-9864-9